Recap: Varian Medical Systems Q1 Earnings

Shares of Varian Medical Systems VAR were flat in after-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share decreased 1.72% year over year to $1.14, which beat the estimate of $1.10.

Revenue of $778,800,000 decreased by 6.04% year over year, which missed the estimate of $842,980,000.

Looking Ahead

Varian Medical Systems hasn't issued any earnings guidance for the time being.

Varian Medical Systems hasn't issued any revenue guidance for the time being.

Recent Stock Performance

52-week high: $176.19

52-week low: $89.62

Price action over last quarter: Up 1.71%

Company Profile

Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (47%), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (19%).